SCHEMBL510762

SCHEMBL510762

NC12CC3CC(C1)CC(N)(C3)C2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 8/20 0.65
GRIN2A Q12879 8/20 0.65
GRIN2D O15399 7/20 0.65
GRIN3B O60391 7/20 0.65
GRIN2B Q13224 7/20 0.65
GRIN2C Q14957 7/20 0.65
GRIN3A Q8TCU5 7/20 0.65
LMNA P02545 4/20 0.65
SLC22A1 O15245 2/20 0.65
NFKB1 P19838 2/20 0.65
SLC22A2 O15244 1/20 0.65
TSHR P16473 1/20 0.65
STAT6 P42226 1/20 0.65
SLC47A1 Q96FL8 1/20 0.65
SIGMAR1 Q99720 1/20 0.65
PKM P14618 1/20 0.64
POLB P06746 2/20 0.61
THRB P10828 2/20 0.61
PMP22 Q01453 2/20 0.61
BLM P54132 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12132159 1.00 GRIN1 (0.65) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL8720366 1.00 GRIN1 (0.65) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL9914296 1.00 GRIN1 (0.65) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL12130587 1.00 GRIN1 (0.65) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Water SCHEMBL28015899 0.97 GRIN1 (0.61) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Hydrochloric Acid SCHEMBL1880961 0.97 LMNA (0.67) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Hydrochloric Acid SCHEMBL866896 0.97 LMNA (0.67) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL1362423 0.85 PKM (0.56) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL4846924 0.84 GRIN1 (0.81) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL18543598 0.81 PKM (0.95) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 704 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119793245-B Application of adamantane-1, 3-diamine in preparing reverse osmosis membrane with controllable desalination performance, reverse osmosis membrane, preparation method and application The Institute Of Seawater Desalination And Multipurpose Utilization, Mnr (tianjin) (CN) 2026-05-26 CN claimed
CN-122006494-A High-flux polyurea acid-resistant nanofiltration membrane and preparation method and application thereof 万华化学集团股份有限公司 2026-05-12 CN claimed
US-20250333579-A1 COMPOSITION AND PACKAGE STRUCTURE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2025-10-30 US claimed
US-20250215292-A1 ADHESIVE AND MULTILAYER STRUCTURE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2025-07-03 US claimed
CN-119793245-A Application of adamantane-1, 3-diamine in preparing reverse osmosis membrane with controllable desalination performance, reverse osmosis membrane, preparation method and application 自然资源部天津海水淡化与综合利用研究所 2025-04-11 CN claimed
CN-118620257-A Durable fresh-locking degradable all-cellulose antibacterial packaging film and preparation method thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2024-09-10 CN claimed
US-11905381-B2 Polyimide microparticles XEROX CORPORATION (US) 2024-02-20 US claimed
CN-117510846-A Polyimide film, preparation method thereof and metallized film capacitor 南方科技大学 2024-02-06 CN claimed
CN-117186399-A Polymer, polymer film and preparation method thereof 华为技术有限公司 2023-12-08 CN claimed
CN-117050256-A Polymerizable composition 华为技术有限公司 2023-11-14 CN claimed
WO-2006093947-A2 SEMI-SYNTHETIC GLYCOPEPTIDES WITH ANTIBIOTIC ACTIVITY NOVARTIS VACCINES AND DIAGNOSTICS INC. (US) 2006-09-08 WO claimed
US-7005248-B2 Method of forming cavity between multilayered wirings JSR CORPORATION (JP) 2006-02-28 US claimed
US-20050245097-A1 Method for synthesizing polymeric material, method for forming polymer thin film and method for forming interlayer insulating film MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-11-03 US claimed
US-6936552-B2 Method for synthesizing polymeric material, method for forming polymer thin film and method for forming interlayer insulating film MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-08-30 US claimed
EP-1493771-A1 METHOD OF SYNTHESIZING POLYMERIC MATERIAL, METHOD OF FORMING THIN POLYMER FILM, AND METHOD OF FORMING INTERLAYER DIELECTRIC MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-01-05 EP claimed
CN-1514850-A Method for synthesizing polymer material, method for forming polymer thin film, and method for forming interlayer insulating film ���µ�����ҵ��ʽ���� 2004-07-21 CN claimed
US-20040087182-A1 Method for synthesizing polymeric material, method for forming polymer thin film and method for forming interlayer insulating film MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD 2004-05-06 US claimed
EP-0317943-A2 Polymers prepared from 4,4'-bis-[2-(3,4-(dicarboxyphenyl) hexafluoroisopropyl] diphenyl ether dianhydride HOECHST CELANESE CORPORATION (US) 1989-05-31 EP claimed
EP-0139504-B1 ADAMANTYLAMINE/LONG CHAIN ALKYLAMINE CATALYSTS AND USE IN PARAFFIN-OLEFIN ALKYLATION PROCESS EXXON RESEARCH AND ENGINEERING COMPANY (US) 1988-06-08 EP claimed
EP-0139504-A1 Adamantylamine/long chain alkylamine catalysts and use in paraffin-olefin alkylation process EXXON RESEARCH AND ENGINEERING COMPANY (US) 1985-05-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245097-A1 Method for synthesizing polymeric material, method for forming polymer thin film and method for forming interlayer insulating film PARG, STOM, DNMT1 GRIN1 192/4885GRIN2A 118/4885GRIN2D 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.